ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 632

The Effects of Co-Existing Proliferative Histopathology On Membranous Lupus Nephritis

Jennifer L. Graybill1, Catarina Vila-Inda1, Chaim Putterman2 and Irene Blanco1, 1Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 2Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Lupus nephritis, outcome measures and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Lupus nephritis (LN) affects up to 60% of SLE patients and is worse in minority communities. Traditionally membranous LN confers a better prognosis than proliferative, but a significant number of patients do develop renal failure. Moreover, mixed membranous and proliferative histology is not uncommon. To determine if co-existing proliferative lesions worsen the prognosis of membranous disease, we studied SLE patients who underwent renal biopsy at a large tertiary center.

Methods:

We analyzed all biopsies with classes: III±V, IV±V and V from January 1997-December 2011, and confirmed that all patients met ≥4/11 ACR SLE criteria. We collected baseline demographic and laboratory information at the time of biopsy as well as medications given. Our composite endpoint was the development of end stage renal disease (ESRD) requiring dialysis and/or death.

Results:  

Of the 202 patients included, 81.3% were female and the median age was 30.5y. The predominant race was black (54.5%), followed by Hispanic (37.1%) and 8.4% were another race/ethnicity. There was no significant difference between the groups in age, gender or disease duration.

 123 patients had proliferative LN (Class III or IV, P), 55 had membranous LN (Class V, M), and 24 had mixed disease (P+M). Black patients were more likely to have class V (p=0.02). Creatinine was higher in P (p<0.01) but there was no difference between M or P+M (p=0.12). There was no difference in median protein to creatinine ratios, serum albumin, and BP between groups.

62/202 (31%) patients reached the composite end point: 41.5% P, 14.6% M, and 12.5% P+M (p<0.01). Survival was significantly worse for P compared to M (p<0.01) and P+M (p=0.05), but no difference was seen between M and P+M (p=0.74). As previously reported, on univariate analyses, urine protein to creatinine ratio (p<0.01), creatinine (p<0.01), systolic BP (p=0.02), and age (p=0.05) were associated with the end point.  There was no association with cyclophosphamide (p=0.07) or mycophenolate induction (p=0.2), ACEI/ARB use (p=0.85), or treatment with anti-malarials (p=0.2).  

In multivariate models, M as compared to P had improved survival (HR=0.31, p=0.02) but there was no longer a significant difference between P and P+M (p=0.18) As in the univariate analysis, age (p=0.03), protein to creatinine ratio (p=0.03), and creatinine at biopsy (p<0.01) were all associated with a decreased risk of survival.

Conclusion:

At first glance membranous with or without proliferative lesions on histology have a similar prognosis. However, in multivariate models the difference between proliferative and mixed disease was no longer seen when adjusted for age, protein to creatinine ratio and creatinine at biopsy. Therefore proliferative lesions alone on biopsy do not confer a worse prognosis for membranous disease rather it is likely disease severity itself that drives prognosis.


Disclosure:

J. L. Graybill,
None;

C. Vila-Inda,
None;

C. Putterman,
None;

I. Blanco,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effects-of-co-existing-proliferative-histopathology-on-membranous-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.